Carlos A. Cañas

Serious liver disease induced by infliximab

Gabriel J. Tobón, Carlos A. Cañas, Juan-Jose Jaller et al. · Clinical Rheumatology · 2006 · 158 citations

Inflammation, Hepatic Disorders, Autoimmune Disease +14

Current Understanding and Management of Chronic Hepatosplenic Suppurative Brucellosis

Javier Ariza, Carlos Pigrau, Carlos A. Cañas et al. · Clinical Infectious Diseases · 2001 · 138 citations · Full text

Calcium Deposits, Hepatology, Liver Physiology +14

The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals

Carlos A. Cañas · Medical Hypotheses · 2020 · 106 citations · Full text

Autoimmune Disease, Covid-19 Pandemic, Immunology +11

Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus

Carlos A. Cañas, Gabriel J. Tobón, Marcela Granados et al. · Clinical Rheumatology · 2007 · 68 citations

Lupus, Lupus Nephritis, Diffuse Alveolar Hemorrhage +2

Efficacy and Safety of Anti–Interleukin 6 Receptor Monoclonal Antibody (Tocilizumab) in Colombian Patients With Takayasu Arteritis

Carlos A. Cañas, Felipe Cañas, Jorge Hernán Izquierdo et al. · JCR Journal of Clinical Rheumatology · 2014 · 53 citations